Bristol-Myers to acquire hepatitis C oral drug developer Inhibitex for $2.5 bn

09 Jan 2012

1

Global biopharma company, Bristol-Myers Squibb over the weekend said that it will buy Inhibitex Inc, for about $2.5 billion in cash in order to expand its broad hepatitis C portfolio.

Under the transaction that has been approved by the boards of both companies, Bristol-Myers will pay $26 per share in cash, a massive 163 per cent premium to Inhibitex's closing price of $9.87 on 6 January.

Stock holders holding approximately 17 per cent of Inhibitex's stock have agreed to tender their shares to the offer.

Inhibitex is a biopharmaceutical company focused on developing products to prevent and treat serious infectious diseases, with primary focus being on the development of nucleotide / nucleoside analogs for the treatment of hepatitis C virus (HCV).

The Alpharetta, Georgia-based company's clinical-stage pipeline includes three Phase 2 development programs, INX-189, a nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C infections, FV-100, a nucleoside inhibitor in development for the reduction of shingles-associated pain, and Aurexis, a humanised monoclonal antibody in development for the treatment of serious S. aureus bloodstream infections.

Latest articles

Senior bankers in PSBs are in firing line: AIBEA

IIT Madras – ISRO to set up Centre of Excellence for research in Fluid and Thermal Sciences

IIT Madras – ISRO to set up Centre of Excellence for research in Fluid and Thermal Sciences

LPG as automobile fuel a solution for Delhi NCR air pollution: IAC

LPG as automobile fuel a solution for Delhi NCR air pollution: IAC

Entry of Starlink and Kuiper could churn India’s telecom sector

Entry of Starlink and Kuiper could churn India’s telecom sector

India building Rs820-cr railway test track in Rajasthan

India building Rs820-cr railway test track in Rajasthan

Rupee falls to 84.37 a dollar as foreign funds withdraw over $2.37 bn from Indian stocks in five days

Rupee falls to 84.37 a dollar as foreign funds withdraw over $2.37 bn from Indian stocks in five days

New central scheme to facilitate guarantee-free loans for higher education

New central scheme to facilitate guarantee-free loans for higher education

Canada ends Student Direct Stream channel for student visas

Canada ends Student Direct Stream channel for student visas

Supreme Court orders liquidation of Jet Airways as debt resolution fails

Supreme Court orders liquidation of Jet Airways as debt resolution fails

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers